Agios Pharmaceuticals
AGIO
#5052
Rank
$1.61 B
Marketcap
$27.73
Share price
1.13%
Change (1 day)
-52.98%
Change (1 year)

Operating Margin for Agios Pharmaceuticals (AGIO)

Operating Margin as of December 2025 (TTM): -1,061.80%

According to Agios Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -1,061.80%. At the end of 2024 the company had an Operating Margin of 1,967.15%.

Operating Margin history for Agios Pharmaceuticals from 2012 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
20241,967.15%-249.86%
2023-1,312.63%-19.36%
2022-1,627.82%
2018-366.61%-49.89%
2017-731.60%157.64%
2016-283.97%42.59%
2015-199.14%141.34%
2014-82.51%-45.71%
2013-151.98%66.43%
2012-91.32%20.86%
2011-75.56%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Xencor
XNCR
-82.45%-92.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
38.16%-103.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
12.60%-101.19%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
21.95%-102.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
22.01%-102.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Eli Lilly
LLY
37.87%-103.57%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.